Completed PHASE4 INTERVENTIONAL 2-arm NCT03278522

Ramosetron Pre-treatment for PONV and QT Prolongation

Comparison of Ramosetron Pre-treatment Time for Postoperative Nausea and Vomiting (PONV) and QTc Prolongation

Sponsor: Konkuk University Medical Center

Interventions Ramosetron

Updated 7 times since 2017 Last updated: Mar 7, 2018 Started: Jul 1, 2017 Primary completion: Feb 28, 2018 Completion: Feb 28, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03278522, this PHASE4 trial focuses on PONV and Prolonged QTc Interval and remains completed. Sponsored by Konkuk University Medical Center, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Mar 2018 — Jun 2018 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Oct 2017 — Mar 2018 [monthly]

Recruiting PHASE4

First recorded

Jul 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Konkuk University Medical Center

Data source: Konkuk University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea